plateauing on tirzepatide Zepbound plateau: why weight loss slows and what to do next Hit plateau after I started

Use requires medical supervision and ongoing monitoring

Identifying a member's struggle, such as disordered eating, creates an opportunity reach out

Tirzepatide is a synthetic peptide that functions as a dual agonist of the GIP and GLP-1 receptors

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest Statements Conflict of interest Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma

Most patients notice improved fasting blood glucose readings within 1-2 weeks of starting tirzepatide, though optimal glycemic control generally develops over 8-12 weeks